In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

NCT06493799 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Liver Disease

Interventions

DRUG: LAENNEC (Human Placenta Hydrolysate) IV
DRUG: LAENNEC (Human Placenta Hydrolysate) SC

Sponsor

Green Cross Wellbeing